Publication | Closed Access

Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential

Medicinal ChemistryMedicineDrug Discovery15-Lox InhibitorsPharmacotherapyPurine-pyrazole HybridsAnti-cancer AgentDrug DevelopmentPharmacologyAntioxidant PotentialBiomolecular Engineering